All Stories

  1. Elicited Repetitive Daily Blindness Associated With Gain-of-Function SCN1A Variants and Responsiveness to Sodium Channel Blockers
  2. Long‐lasting remodeling of astrocytes in an Scna1 +/− mouse model of Dravet syndrome
  3. Non-syndromic autism SCN2A variants selectively exert dominant-negative effects on Na v 1.2 channels
  4. Long-lasting astrocyte remodeling in Dravet Syndrome Scn1a +/– mouse model
  5. Artificial intelligence‐driven closed‐loop devices in sudden unexpected death in epilepsy prediction and prevention: Insights from persons with epilepsy and caregivers
  6. Sex‐Specific Behavioral Features of Juvenile and Adult Haploinsufficient Scn2a +/− Female Mice, Model of Autism Spectrum Disorder
  7. GABAergic neurons can facilitate the propagation of cortical spreading depolarization: experiments in mouse neocortical slices and a novel neural field computational model
  8. Neurodevelopmental defects in Dravet syndrome Scn1a+/− mice: Targeting GABA-switch rescues behavioral dysfunctions but not seizures and mortality
  9. The role of electroencephalography in epilepsy research—From seizures to interictal activity and comorbidities
  10. WONOEP appraisal: Targeted therapy development for early onset epilepsies
  11. GABAergic neurons can facilitate the propagation of cortical spreading depolarization: experiments in mouse neocortical slices and a novel neural field computational model
  12. Perturbed interneurons' activity leads to seizures in Dravet syndr.: biomarker for their prediction.
  13. Sudden brainstem malfunction explains life-threatening apnea
  14. Neurodevelopmental defects in Dravet syndromeScn1a+/-mice: selective rescue of behavioral alterations but not seizures by targeting GABA-switch
  15. Sex-specific behavioral features of juvenile and adult haploinsufficientScn2a+/−female mice, model of Autism Spectrum Disorder
  16. Are we there yet? A critical evaluation of sudden and unexpected death in epilepsy models
  17. Preictal dysfunctions of inhibitory interneurons paradoxically lead to their rebound hyperactivity and to Low-Voltage-Fast onset seizures in Dravet syndrome
  18. Structure-function relationship of new peptides activating human Nav1.1
  19. Voltage‐gated sodium channels in genetic epilepsy: up and down of excitability
  20. Idealized multiple-timescale model of cortical spreading depolarization initiation and pre-epileptic hyperexcitability caused by NaV1.1/SCN1A mutations
  21. Involvement of GABAergic Interneuron Subtypes in 4-Aminopyridine-Induced Seizure-Like Events in Mouse Entorhinal Cortexin Vitro
  22. Gain of function SCN1A disease‐causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication
  23. Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum
  24. Predictive precision medicine efforts for voltage-gated sodium channel genetic variants
  25. A companion to the preclinical common data elements for rodent models of pediatric acquired epilepsy: A report of the TASK3‐WG1B, Pediatric and Genetic Models Working Group of the ILAE/AES Joint Translational Task Force
  26. A companion to the preclinical common data elements for rodent genetic epilepsy models. A report of the TASK3‐WG1B: Paediatric and genetic models working group of the ILAE/AES joint translational TASK force
  27. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications
  28. A python-based package for long-lasting video acquisition and semi-automated detection of convulsive seizures in rodents
  29. Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K)
  30. Initiation of migraine-related cortical spreading depolarization by hyperactivity of GABAergic neurons and NaV1.1 channels
  31. Sodium channelopathies of skeletal muscle and brain
  32. Modeling NaV1.1/SCN1A sodium channel mutations in a microcircuit with realistic ion concentration dynamics suggests differential GABAergic mechanisms leading to hyperexcitability in epilepsy and hemiplegic migraine
  33. Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic eEF2K
  34. Histone Deacetylase Inhibitors Ameliorate Morphological Defects and Hypoexcitability of iPSC-Neurons from Rubinstein-Taybi Patients
  35. Fluorescent‐ and tagged‐protoxin II peptides: potent markers of the Nav1.7 channel pain target
  36. SULT4A1 Modulates Synaptic Development and Function by Promoting the Formation of PSD-95/NMDAR Complex
  37. Cholinergic modulation inhibits cortical spreading depression in mouse neocortex through activation of muscarinic receptors and decreased excitatory/inhibitory drive
  38. GABAergic neurons and NaV1.1 channel hyperactivity: a novel neocortex-specific mechanism of Cortical Spreading Depression
  39. SCN1A/NaV1.1 channelopathies: Mechanisms in expression systems, animal models, and human iPSC models
  40. Modeling cortical spreading depression induced by the hyperactivity of interneurons
  41. NaV1.2 haploinsufficiency in Scn2a knock-out mice causes an autistic-like phenotype attenuated with age
  42. Hyperexcitability in Cultured Cortical Neuron Networks from the G93A-SOD1 Amyotrophic Lateral Sclerosis Model Mouse and its Molecular Correlates
  43. A two-hit story: Seizures and genetic mutation interaction sets phenotype severity in SCN1A epilepsies
  44. Animal Models of Causation of Epilepsy
  45. SULTA4A1 modulates synaptic development and function by promoting the formation of PSD-95/NMDAR complex
  46. Hyperactive and anxiolytic‐like behaviors result from loss of COUP‐TFI/Nr2f1 in the mouse cortex
  47. DNA damage and transcriptional regulation in iPSC-derived neurons from Ataxia Telangiectasia patients
  48. A gain-of-function sodium channelβ2-subunit mutation in painful diabetic neuropathy
  49. New Insights Into the Role of Cav2 Protein Family in Calcium Flux Deregulation in Fmr1-KO Neurons
  50. Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study
  51. Gain of Function for the SCN1A/hNav1.1-L1670W Mutation Responsible for Familial Hemiplegic Migraine
  52. iPSC-derived neurons of CREBBP - and EP300 -mutated Rubinstein-Taybi syndrome patients show morphological alterations and hypoexcitability
  53. Post-translational dysfunctions in channelopathies of the nervous system
  54. Epilepsy: Advances in genetics and pathophysiology
  55. Pathophysiological mechanisms of migraine and epilepsy: Similarities and differences
  56. The impact of genetic and experimental studies on classification and therapy of the epilepsies
  57. Revealing the involvement of miR-376a, miR-432 and miR-451a in infantile ascending hereditary spastic paralysis by microRNA profiling in iPSCs
  58. Identification of two mutations in cis in the SCN1A gene in a family showing genetic epilepsy with febrile seizures plus (GEFS+) and idiopathic generalized epilepsy (IGE)
  59. The X-Linked Intellectual Disability Protein IL1RAPL1 Regulates Dendrite Complexity
  60. Homer1b/c clustering is impaired in Phelan-McDermid Syndrome iPSCs derived neurons
  61. Network topology of NaV1.7 mutations in sodium channel-related painful disorders
  62. Sodium channels and channelopathies: Neuropathic pain, epilepsies, migraine
  63. Ranolazine vs phenytoin: greater effect of ranolazine on the transient Na+ current than on the persistent Na+ current in central neurons
  64. A cell model for Fragile X syndrome
  65. Erratum: Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice
  66. Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice
  67. Unaltered Network Activity and Interneuronal Firing During Spontaneous Cortical Dynamics In Vivo in a Mouse Model of Severe Myoclonic Epilepsy of Infancy
  68. Rescuable folding defective NaV1.1 (SCN1A) mutants in epilepsy: Properties, occurrence, and novel rescuing strategy with peptides targeted to the endoplasmic reticulum
  69. Mutations of Ion Channels in Genetic Epilepsies
  70. Impaired Action Potential Initiation in GABAergic Interneurons Causes Hyperexcitable Networks in an Epileptic Mouse Model Carrying a Human NaV1.1 Mutation
  71. Action Potential Initiation in Neocortical Inhibitory Interneurons
  72. Functional and molecular defects of hiPSC-derived neurons from patients with ATM deficiency
  73. Genetic Epilepsy Syndromes Without Structural Brain Abnormalities: Clinical Features and Experimental Models
  74. Nonfunctional Na V 1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects
  75. Loss‐of‐function KCNH2 mutation in a family with long QT syndrome, epilepsy, and sudden death
  76. Hippocampal hyperexcitability and specific epileptiform activity in a mouse model of Dravet syndrome
  77. Divergent effects of the T1174S SCN1A mutation associated with seizures and hemiplegic migraine
  78. Phenytoin Inhibits the Persistent Sodium Current in Neocortical Neurons by Modifying Its Inactivation Properties
  79. Comparative neuronal differentiation of self-renewing neural progenitor cell lines obtained from human induced pluripotent stem cells
  80. The 22nd Ion Channel Meeting, September 2011, France
  81. Pure haploinsufficiency for Dravet syndrome NaV1.1 (SCN1A) sodium channel truncating mutations
  82. Dravet syndrome: Insights from in vitro experimental models
  83. Voltage‐gated Na+ channels and epilepsy
  84. Epileptogenic ion channel mutations: From bedside to bench and, hopefully, back again
  85. Na+channelopathies and epilepsy: recent advances and new perspectives
  86. Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders
  87. Progressive neurocognitive decline in two children with Dravet syndrome, de novo SCN1A truncations and different epileptic phenotypes
  88. A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+) mutation
  89. A rescuable folding defective Nav1.1 (SCN1A) sodium channel mutant causes GEFS+: Common mechanism in Nav1.1 related epilepsies?
  90. Self-Limited Hyperexcitability: Functional Effect of a Familial Hemiplegic Migraine Mutation of the Nav1.1 (SCN1A) Na+Channel
  91. Modulatory Proteins Can Rescue a Trafficking Defective Epileptogenic Nav1.1 Na+Channel Mutant
  92. Electroclinical Features of a Family with Simple Febrile Seizures and Temporal Lobe Epilepsy Associated with SCN1A Loss-of-Function Mutation
  93. Epileptogenic Channelopathies: Experimental Models of Human Pathologies
  94. Phosphorylation of sodium channels mediated by protein kinase‐C modulates inhibition by topiramate of tetrodotoxin‐sensitive transient sodium current
  95. Erratum: Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy
  96. Effects in Neocortical Neurons of Mutations of the Nav1.2 Na+Channel causing Benign Familial Neonatal-Infantile Seizures
  97. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy
  98. Layer-Specific Properties of the Persistent Sodium Current in Sensorimotor Cortex
  99. Identification of an Na v 1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures
  100. β‐Scorpion toxin effects suggest electrostatic interactions in domain II of voltage‐dependent sodium channels
  101. A new type of scorpion Na+-channel-toxin-like polypeptide active on K+ channels
  102. Molecular Determinants for Modulation of Persistent Sodium Current by G-Protein βγ Subunits
  103. First chemical synthesis of a scorpion α‐toxin affecting sodium channels: The Aah I toxin of Androctonus australis hector
  104. Protein-kinase C-dependent phosphorylation inhibits the effect of the antiepileptic drug topiramate on the persistent fraction of sodium currents
  105. Role of the C-terminal domain in inactivation of brain and cardiac sodium channels
  106. Neutralization of Gating Charges in Domain II of the Sodium Channel α Subunit Enhances Voltage-Sensor Trapping by a β-Scorpion Toxin
  107. Valproate selectively reduces the persistent fraction of Na+ current in neocortical neurons
  108. Modalities of Distortion of Physiological Voltage Signals by Patch-Clamp Amplifiers: A Modeling Study
  109. Anemone toxin (ATX II)‐induced increase in persistent sodium current: effects on the firing properties of rat neocortical pyramidal neurones
  110. Action potentials recorded with patch-clamp amplifiers: are they genuine?
  111. Stimulation of single L-type calcium channels in rat pituitary GH3 cells by thyrotropin-releasing hormone.
  112. Muscarinic Regulation of Ca2+Currents in Rat Sensory Neurons: Channel and Receptor Types, Dose - response Relationships and Cross-talk Pathways